HEDIS® Results

Medicaid HEDIS® Annual Rates.

Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.

Measure/Data Element

2020

2021

2021 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

64.42%

72.58%

67.62%

Annual Dental Visits (ADV) Total

NB

NB

49.95%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

41.53%

52.60%

42.97%

Appropriate Testing for Pharyngitis (CWP)

70.10%

73.49%

80.59%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

87.53%

89.78%

90.81%

Asthma Medication Ratio (AMR) Total

81.82%

79.80%

68.24%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

57.97%

61.47%

59.51%

Breast Cancer Screening (BCS)

69.21%

62.18%

56.72%

Cervical Cancer Screening (CCS)

63.26%

65.94%

61.80%

Childhood Immunization Status (CIS) Combination #10

38.05%

45.26%

42.34%

Chlamydia Screening in Women (CHL) Total

67.81%

64.84%

60.28%

Comprehensive Diabetes Care (CDC) BP Control < 140/90

71.05%

64.23%

63.26%

Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0%

56.93%

53.04%

49.64%

Comprehensive Diabetes Care (CDC) Eye Exam

65.21%

55.83%

55.96%

Controlling High Blood Pressure (CBP)

72.13%

62.29%

60.10%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

85.74%

78.31%

78.90%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

5.92%

6.94%

16.38%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

22.39%

30.00%

46.38%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

38.83%

37.77%

44.82%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

62.59%

56.82%

60.35%

Immunizations for Adolescents (IMA) Combination #2

43.41%

47.45%

41.81%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

7.45%

5.88%

16.45%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

44.55%

35.29%

34.89%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

68.53%

61.43%

73.66%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

91.37%

73.57%

86.99%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

99.03%

88.81%

88.32%

Prenatal and Postpartum Care (PPC) Postpartum Care

77.13%

75.18%

78.35%

Risk of Continued Opioid Use (COU) 31-Day Total

4.16%

2.89%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

79.77%

75.43%

81.90%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

64.59%

73.86%

74.98%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

76.06%

70.44%

68.57%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

60.66%

65.92%

71.95%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

77.39%

69.57%

66.87%

Use of Imaging Studies for Low Back Pain (LBP)

66.41%

71.15%

77.76%

Use of Opioids at High Dosage (HDO)

13.55%

10.46%

≤ 2.87%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

2.04%

1.85%

≤ 1.21%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

89.74%

88.32%

80.67%

The reporting year is subsequent of the year reflected in the data; for example, “HEDIS 2020” is data collected from calendar year January-December 2019.

NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate